MOU with Kingdom of Saudi Arabia for MT-RNR1 ID

genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, announces that genedrive's exclusive distribution partner in the Kingdom of Saudi Arabia ("KSA"), iDeal iDea for Medical Equipment Technology has signed a Memorandum of Understanding ("MOU") with the KSA Ministry of Health ("MOH"). The MOU scope is to pilot the Genedrive® MT-RNR1 ID Kit for potential national implementation under a national initiative "Generations Hear".

The MOU was signed by Hatim Najjar, Founder and CEO of iDeal iDea, Dr Abdullah Al-Sohimi, General Director of Specialized Centers at Ministry of Health, and Dr Salem Baharoon, Deputy Minister for Therapeutic Services, Ministry of Health.

This initiative aligns with the Saudi Vision 2030, supporting the national objective of advancing precision medicine, enhancing quality of life, and transforming healthcare from reactive treatment to proactive prevention, from disease management to preventive care, and from pain to hope.

Dr Gino Miele, CEO of genedrive plc, said: "We are delighted with the signing of this MOU, which builds further on our commercial traction in Saudi Arabia and aligns perfectly to the long-term Saudi health goals. We are grateful to our valued partners at iDeal iDea for their support and look forward to progressing through pilot phase with the goal of implementation at national level."

Hatim Najjar, Founder and CEO of iDeal iDea for Medical Equipment Technology, said: "The Generations Hear initiative embodies Saudi Arabia's true transformation in the healthcare sector, leveraging genetic innovation to safeguard the health and lives of future generations. At iDeal iDea for Medical Equipment Technology, we are proud to provide innovative medical solutions in line with Saudi Vision 2030 and the Health Transformation Program, through national partnerships that advance precision medicine and strengthen preventive healthcare."